Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CINTEX

K-Number: K903605 · 1990-09-14

ApplicantNanopac, Inc.
Decision Date1990-09-14
Product CodeILQ
Advisory CommitteePM
DecisionSubstantially Equivalent

Device Summary

CINTEX is the device name listed in this FDA 510(k) record. The listed applicant is Nanopac, Inc.. It received FDA 510(k) clearance on 1990-09-14 under 510(k) number K903605. The device is classified under product code ILQ. It was reviewed by the PM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CINTEX?

CINTEX is a medical device that received FDA 510(k) clearance on 1990-09-14. The listed applicant is Nanopac, Inc.. The 510(k) number is K903605.

When did CINTEX receive FDA 510(k) clearance?

CINTEX received FDA 510(k) clearance on 1990-09-14, under 510(k) number K903605.

Who is the listed applicant for CINTEX?

The FDA 510(k) record lists Nanopac, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for CINTEX?

The FDA product code for CINTEX is ILQ.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: ILQ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑